High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms

Sampaio, Leticia Rodrigues; Viana, Mateus de Aguiar; de Oliveira, Vanessa Silva; Ferreira, Bruna Vitoriano; Melo, Mayara Magna Lima; de Oliveira, Roberta Taiane Germano; Borges, Daniela de Paula; Magalhãesa, Silvia Maria Meira; Pinheiro, Ronald F.

doi:10.1016/j.htct.2023.05.002

Cited by 2 publications

(2 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In relation to our publication, we verified that when searching for "Myelodysplastic syndrome" and reviewing the latest 100 articles resulting from this search, our publication doesn't even appear on the list in the PubMed database. This issue has been encountered with other publications from our group as well [6,7]. This raises an important question: is the confusion of clinical terms causing confusion in PubMed's own search algorithm?.…”

Section: Introductionmentioning

confidence: 83%

From Myelodysplastic Syndrome to Myelodysplastic Neoplasm: The Impact of WHO's Reclassification on MDS Research

Gusmão,

Carneiro,

Ribeiro-Junior

2024

Braz. J. Clin. Med. Rev.

View full text Add to dashboard Cite

This letter addresses the challenges posed by the recent reclassification of Myelodysplastic Syndromes (MDS) to Myelodysplastic Neoplasm (maintaining the acronym MDS) by the World Health Organization (WHO). Despite the clinical and scientific justification for this change, the adoption of the new terminology in the research community has been slow, leading to decreased visibility and citation of studies using the updated nomenclature. Here, it was proposed a gradual transition where both terminologies are used simultaneously in research articles to maintain research visibility while educating the medical community about the new terminology. Furthermore, it is suggested that major databases and search engines update their algorithms to link both terms, ensuring comprehensive search results. The role of international medical societies and scientific journals in promoting the use of the new terminology is also emphasized.

show abstract

Section: Introductionmentioning

confidence: 83%

From Myelodysplastic Syndrome to Myelodysplastic Neoplasm: The Impact of WHO's Reclassification on MDS Research

Gusmão,

Carneiro,

Ribeiro-Junior

2024

Braz. J. Clin. Med. Rev.

View full text Add to dashboard Cite

show abstract

“…et al e Viana, M.A. et al published in this edition of "Hematology, Transfusion and Cell Therapy”, discuss relevant hematological diseases under the Brazilian perspective 8 , 9 , 10 , 11 .…”

mentioning

confidence: 99%

Are we securing our future workforce of physician-scientists in hematology?

Facco,

De Paula

2024

Hematology, Transfusion and Cell Therapy

View full text Add to dashboard Cite

High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms

Cited by 2 publications

References 37 publications

From Myelodysplastic Syndrome to Myelodysplastic Neoplasm: The Impact of WHO's Reclassification on MDS Research

From Myelodysplastic Syndrome to Myelodysplastic Neoplasm: The Impact of WHO's Reclassification on MDS Research

Are we securing our future workforce of physician-scientists in hematology?

Contact Info

Product

Resources

About